Demographics (2)
- sex - Gender of participant (phv00427154.v1.p1)
- SEX - Genetic sex of the subject (phv00533175.v1.p1)
Disease Events (1)
- af_status - AF status (phv00427153.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00427155.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00427158.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00427157.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00427148.v1.p1)
- Funding_Source - Project funding source (phv00427161.v1.p1)
- IS_TUMOR - Tumor status (phv00427159.v1.p1)
- SAMPLE_ID - Sample ID (phv00427156.v1.p1)
- SAMPLE_ID - Sample ID (phv00427151.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00427160.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00427164.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00427152.v1.p1)
- SUBJECT_ID - Subject ID (phv00427147.v1.p1)
- SUBJECT_ID - Subject ID (phv00427150.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00427162.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00427163.v1.p1)